FDA Adverse Event Injury Summary report: N

ASR XL TAP SLV ADAP 12/14+5

MDR report key: 2823314 · Received November 7, 2012

Report

Report Number
1818910-2012-24466
Event Type
Injury
Date Received
November 7, 2012
Date of Event
August 12, 2011
Report Date
April 22, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z- 1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT - ASR REVISION RECOMMENDED, RIGHT ASR XL ACETABULAR SYSTEM. UPDATE: HOSPITAL AND DATE OF REVISION CONFIRMED (B)(6) 2012. UPDATE- ADDED SLEEVE TAKEN FROM CLAIMSUITE DATED (B)(6) 2012. UPDATE - ADDED REASON FOR REVISION, TAKEN FROM CLAIMSUITE DATED (B)(6) 2014. REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION.

Description of Event or Problem · 1

ASR REVISION RIGHT ASR XL ACETABULAR SYSTEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASR XL TAP SLV ADAP 12/14+5 ASR TOTAL HIP REPLACEMENT KWA DEPUY INTERNATIONAL LTD. 8010379 2715494

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention